| Annual · values | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | -14.67 M USD | 2.72 M USD | 3.14 M USD | 2.34 M USD |
| Depreciation & Amortization | 928633 USD | 528728 USD | 557128 USD | 440470 USD |
| Stock-Based Compensation | — | — | — | — |
| Capital Expenditures | -437880 USD | -7920 USD | -6162 USD | -67682 USD |
| Cash Flow from Investing | — | — | — | — |
| Cash Flow from Financing | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock Buybacks | — | — | — | — |
| Free Cash Flow | -3.62 M USD | 2.50 M USD | 2.59 M USD | 2.07 M USD |
Basel Medical Group Ltd is a Singapore-based healthcare provider specializing in orthopedic, trauma, and sports medicine services. The company offers general and subspecialized orthopedic care including knee and hip replacements, spine surgery, foot and ankle procedures, and minimally invasive orthopedic treatments, alongside neurosurgical services. Basel Medical operates a network of clinics across Singapore and provides consultation, medical diagnosis, surgical treatments, physiotherapy, and related services for orthopedic and neurological conditions. Beyond clinical services, the company serves corporate clients in construction, marine, and oil and gas industries through occupational health and executive health screening programs. The company also expanded its service offerings through the acquisition of Bethesda Medical, adding diagnostic imaging, outpatient care, and mental health services to its portfolio. Additionally, Basel Medical holds contracts for healthcare product supply in the Asia-Pacific region and is integrating AI-powered technologies into its healthcare supply chain operations to enhance logistics and service delivery.